Nephros, Inc (NEPH)

Etorro trading 970x250
Nephros, Inc (NEPH) Logo

About Nephros, Inc

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company develops and sells water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. Nephros, Inc. was incorporated in 1997 and is headquartered in South Orange, New Jersey. Address: 380 Lackawanna Place, South Orange, NJ, United States, 07079

Nephros, Inc News and around…

Latest news about Nephros, Inc (NEPH) common stock and company :

Nephros Announces Preliminary Results for Third Quarter of 2021
08 Oct, 2021 FinancialContent
Nephros to Present at the LD Micro Main Event
05 Oct, 2021 FinancialContent
Nephros to Present at the LD Micro Main Event
05 Oct, 2021 Yahoo! Finance

SOUTH ORANGE, NJ, Oct. 05, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing innovative filtration and pathogen detection solutions to healthcare and commercial markets, today announced it has been selected to present at the 14th Annual LD Micro Main Event on Tuesday, October 12, 2021 at 12:30 pm ET at the Luxe Sunset Bel-Air in Los Angeles. The Nephros presentation will be delivered by CEO, Andy Astor. For more information ab

Nephros to Present at the Virtual MicroCap Leadership Summit
15 Sep, 2021 FinancialContent
12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
09 Sep, 2021 FinancialContent

Gainers Torrid Holdings (NYSE:CURV) stock increased by 30.44% to $24.08 during Thursday's regular session. As of ...

Bullish insiders bet US$699k on Nephros, Inc. (NASDAQ:NEPH)
06 Sep, 2021 Yahoo! Finance

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Nephros Appoints Wes Lobo to Chief Commercial Officer
01 Sep, 2021 FinancialContent
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
11 Aug, 2021 FinancialContent

Gainers LightInTheBox Holding (NYSE:LITB) stock increased by 18.03% to $1.44 during Wednesday's regular session. The ...

Nephros Announces Results for Quarter Ended June 30, 2021
05 Aug, 2021 FinancialContent
Will Nephros Inc. (NEPH) Report Negative Q2 Earnings? What You Should Know
28 Jul, 2021 Yahoo! Finance

Nephros Inc. (NEPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nephros Announces Acquisition of GenArraytion, Inc.
12 Jul, 2021 FinancialContent
Nephros CEO Presenting at Access to Giving Virtual Investor Conference
09 Jul, 2021 FinancialContent
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
08 Jul, 2021 Yahoo! Finance

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13th \- 15th, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meetings with qualified investors throughout the event.

Nephros Sees 40% Increase In Q2 Sales, Submits HDF Product For FDA Approval
08 Jul, 2021 FinancialContent

Nephros Inc(NASDAQ: NEPH) has announced preliminary results andexpects Q2 sales of approximately $2.2 million, ...

Nephros Announces Preliminary Results for Second Quarter of 2021
08 Jul, 2021 FinancialContent
Did Business Growth Power Nephros' (NASDAQ:NEPH) Share Price Gain of 227%?
08 Jul, 2021 Yahoo! Finance

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

58 Biggest Movers From Yesterday
30 Jun, 2021 FinancialContent

Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly ...

Stocks That Hit 52-Week Highs On Tuesday
29 Jun, 2021 FinancialContent

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest ...

Here's What Could Help Nephros Inc. (NEPH) Maintain Its Recent Price Strength
29 Jun, 2021 Yahoo! Finance

Nephros Inc. (NEPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

What Makes Nephros Inc. (NEPH) a Good Fit for "Trend Investing"
31 May, 2021 Yahoo! Finance

Nephros Inc. (NEPH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Nephros Announces Results for Quarter Ended March 31, 2021
06 May, 2021 FinancialContent
Nephros, Inc. to Host Earnings Call
06 May, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / Nephros, Inc. (NASDAQ:NEPH) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time.

Nephros Announces First Quarter 2021 Financial Results Conference Call
26 Apr, 2021 FinancialContent
A Look At The Fair Value Of Nephros, Inc. (NASDAQ:NEPH)
09 Apr, 2021 Yahoo! Finance

How far off is Nephros, Inc. ( NASDAQ:NEPH ) from its intrinsic value? Using the most recent financial data, we'll take...

54 Biggest Movers From Yesterday
06 Apr, 2021 FinancialContent

Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares climbed 60.2% to close at $5.64 on Monday after the company announced the ...

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
05 Apr, 2021 FinancialContent

Gainers Xcel Brands (NASDAQ:XELB) stock moved upwards by 71.5% to $3.31 during Monday's regular session. Trading ...

Nephros Announces Preliminary Results for First Quarter of 2021
05 Apr, 2021 FinancialContent
Nephros Inc. (NASDAQ: NEPH) Featured in Virtual Coverage of Investor Summit Group’s Q1 Virtual Summit
22 Mar, 2021 FinancialContent
Nephros to Present at the Q1 Virtual Investor Summit
16 Mar, 2021 FinancialContent
Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
10 Mar, 2021 FinancialContent

Nephros, Inc (NEPH) is a NASDAQ Common Stock listed in , ,

970x250